TrialJCI insight2018

The DILfrequency study is an adaptive trial to identify optimal IL-2 dosing in patients with type 1 diabetes.

Eleonora Seelig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.